DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Dr Reddys Share Price Live Updates: Current market performance of Dr. Reddys

Economic Times 4 hrs ago·16 Sept 2026, 2:41 am

Dr. Reddys Laboratories, a major player in the global pharmaceutical sector, is currently seeing active trading on the stock market. As a large-cap company, its shares are closely watched by investors for broader market sentiment towards Indian healthcare and pharma stocks.

For investors, the company's performance is often linked to its diverse product portfolio and global expansion efforts. Any significant movement in its share price can signal shifts in investor confidence regarding the company's growth trajectory or the broader sector.

Moving forward, market participants should monitor the stock's trading volume and key support levels. Keeping an eye on broader market trends and sector-specific news will help in understanding the current price action and potential future direction.